New study associates mask laws to reduction of COVID-19 deaths

Countries without face mask mandates experienced significantly higher COVID-19 deaths per million than countries that enacted mask mandates, investigators report in the American Journal of Preventive Medicine

Ann Arbor, December 15, 2021

A study of the impact of national face mask laws on COVID-19 mortality in 44 countries with a combined population of nearly one billion people found that, over time, the increase in COVID-19 related deaths was significantly slower in countries that imposed mask laws compared to countries that did not. The study, appearing in the American Journal of Preventive Medicine, published by Elsevier, shows that masks provide a supplementary layer of protection that could prevent unnecessary COVID-19 deaths.

“While several studies before this have looked at the impact of masks on COVID-19 cases, fewer studies were focused on whether mask wearing may reduce COVID-19 deaths, and no study had looked at the data across multiple countries,” said lead investigator Sahar Motallebi, MD, MPH, from Malmö, Sweden. “The large sample of culturally diverse countries in this retrospective study covers a large population, giving us more evidence towards the life-saving potential of masks during the COVID-19 pandemic.”

The top 50 countries according to the United Nations Development Programme Human Development Index, which measures life expectancy, education, and standard of living, were targeted because of comparability and reduced chance of selection bias. Four countries in the Southern Hemisphere (New Zealand, Australia, Chile, and Argentina) were excluded to avoid potential seasonality characteristics. The United States and Canada were excluded because public health policies are made at the state/province level and a unified national policy does not exist. Data from the remaining 44 countries were used to model COVID-19 mortality.

Twenty-seven countries with face mask policies and 17 countries without face mask policies, covering a combined population of nearly one billion people, were included in the study. Investigators looked at COVID-19 deaths between February 15, 2020, the date of the first confirmed death in the targeted countries, to May 31, 2020, when many countries began to lift gathering and movement restrictions. Ten relevant demographic, social, clinical and time-dependent factors were examined. Potential confounders between face mask policy and mortality reduction, such as non-pharmaceutical interventions, were identified.

The 44 countries studied reported 2,167,664 confirmed deaths, 1,253,757 in countries without face mask mandates and 913,907 in countries with face mask mandates. The average COVID-19 mortality per million population was 48.40 in countries with face mask policies and 288.54 in countries without face mask policies, and this was significantly greater compared to countries with mask mandates. Face mask countries had significantly lower average daily increase in deaths compared to no face mask countries.

Surprisingly, the countries with no mask mandate started with a lower COVID-19 daily mortality. However, the death rate accelerated so fast in those countries that they not only caught up with the death rate in mask law countries, but significantly surpassed them over time.

Predicted average COVID-19 mortality over time in countries with and without facemask laws. Countries with no facemask laws have a lower average daily mortality per million population at baseline compared to countries with a facemask law. The rate of increase of daily mortality per million population is significantly lower in countries with a facemask law compared to the rate of increase in countries without a facemask law. Therefore, over time the average daily mortality per million population of countries with no mask policy surpasses and exceeds the average daily mortality per million population in countries with a mandated mask law (Credit: American Journal of Preventive Medicine).

“To reach its full potential of saving lives, public health research should be practical and pragmatic,” Dr. Motallebi stressed. “Our primary objective was to assess lessons learned from the pandemic in order to better prepare for future potential epidemics of airborne diseases, before pharmaceutical interventions are available.”

As delays in vaccination continue to challenge heath systems across the globe, the study adds evidence that before, and even after, full vaccination of the population, face masks continue to be a preventive measure against COVID-19.

“Across variants, vaccines may reduce mortality but not necessarily morbidity, and face masks continue to protect against both. So, we don't have to choose between these two good policies of vaccination and face masks or substitute one for the other when we can and must do both in parallel,” Dr. Motallebi concluded.


Notes for editors
The article is“Modeling COVID-19 Mortality Across 44 Countries: Face Covering May Reduce Deaths,” by Sahar Motallebi, MD, MPH, Rex C.Y. Cheung, PhD, Babak Mohit, DrPH, Shahram Shahabi, MD, PhD, Amir Alishahi Tabriz, MD, PhD, and Syamak Moattari, MD, DrPH ( Published online in advance of the American Journal of Preventive Medicine, volume 62, issue 4 (April 2022), published by Elsevier.

The article is openly available at

Full text of this article is also available to credentialed journalists upon request; contact Jillian B. Morgan at +1 734 936 1590 or Journalists wishing to interview the authors should contact corresponding author, Dr. Babak Mohit, at

Elsevier’s Novel Coronavirus Information Center provides expert-curated information for researchers, healthcare professionals and public health officials, including clinical guidance and a portal to access all of Elsevier’s COVID-19 research. All resources are freely available. We also have dedicated hubs for healthcare professionals; health educators and students; librarians; and R&D professionals. You can find these in our Coronavirus Resource Directory.

About the American Journal of Preventive Medicine
The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials.

About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

Media contact
Jillian B. Morgan, MPH, Managing Editor
+1 734 936 1590